iLab Polaris Multi-Modality Guidance System— 510(k) K210889

Name: FDA 510(k) clearance K210889
Creator: U.S. Food and Drug Administration
Published: 2021-06-25

Substantially Equivalent

Boston Scientific Corporation

FDA 510(k) clearance K210889 for iLab Polaris Multi-Modality Guidance System, Substantially Equivalent on 2021-06-25. Applicant: Boston Scientific Corporation. Device class: 2.

Clearance details

Applicant: Boston Scientific Corporation
Product code: Code DQK
Device class: Class 2
Regulation: 21 CFR 870.1425
Advisory panel: Cardiovascular
Date received: 2021-03-25
Decision date: 2021-06-25
Decision: Substantially Equivalent
Clearance type: Special
Location: Maple Grove, MN, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code DQK

view all

K253692 — AVVIGO+ Multi-Modality Guidance System2026-08-21
K262005 — Affera Integrated Mapping System2026-08-21
K253576 — CorVista System® with PCWP Add-On2026-07-26
K262006 — EnSite X EP System2026-07-15
K252978 — ScioCardio ECG Analysis Platform2026-07-09

More clearances from Boston Scientific Corporation

view all

K262151 — SpaceOAR Flex System2026-09-11
K261153 — LithoVue Elite Digital Flexible Ureteroscope System2026-08-26
K261915 — Navigator Flex Ureteral Access Sheath Set2026-08-04
K261488 — OBSIDIO Conformable Embolic2026-07-24
K262165 — FARADRIVE Steerable Sheath (M004PF21M402)2026-07-24

Adverse events under product code DQK

product code DQK

Death: 10
Injury: 225
Malfunction: 2,123
Other: 2
Total: 2,360

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.